Depression and frailty in later life: A systematic review

Clinical Interventions in Aging

Volumn 10, Issue , 2015, Pages 1947-1958

  Vaughan, Leslie ^a   Corbin, Akeesha L ^a   Goveas, Joseph S ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Aging; Depression; Depressive symptomatology; Frailty

Indexed keywords

ANTIDEPRESSANT AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANEMIA; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; COMORBIDITY; CONSTRUCT VALIDITY; DEMENTIA; DEPRESSION; DISEASE SEVERITY; DRUG USE; FRAILTY; HEALTH; HIP FRACTURE; HUMAN; INCIDENCE; NUTRITION; OSTEOPENIA; PREVALENCE; REVIEW; SARCOPENIA; SYNDROME; SYSTEMATIC REVIEW; UNDERWEIGHT; AGED; AGING; FRAIL ELDERLY; MIDDLE AGED; PSYCHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; COMORBIDITY; DEPRESSION; FRAIL ELDERLY; HUMANS; MIDDLE AGED; PREVALENCE;

EID: 84949990899     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S69632     Document Type: Review

References (71)

1. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3): M146-M157. doi: 10. 1093/gerona/56. 3. M146.
2. Fried LP, Borhani NO, Enright P, et al. The cardiovascular health study: design and rationale. Ann Epidemiol. 1991; 1(3): 263-276. doi: 10. 1016/1047-2797(91)90005-W.
3. Rockwood K, Fox RA, Stolee P, Robertson D, Beattie BL. Frailty in elderly people: an evolving concept. CMAJ. 1994; 150(4): 489-495.
4. Strawbridge WJ, Shema SJ, Balfour JL, Higby HR, Kaplan GA. Antecedents of frailty over three decades in an older cohort. J Gerontol B Psychol Sci Soc Sci. 1998; 53B(1): S9-S16. doi: 10. 1093/geronb/53B. 1. S9.
5. Cigolle CT, Ofstedal MB, Tian Z, Blaum CS. Comparing models of frailty: The Health and Retirement Study. J Am Geriatr Soc. 2009; 57(5): 830-839. doi: 10. 1111/j. 1532-5415. 2009. 02225. x.
6. Mezuk B, Edwards L, Lohman M, Choi M, Lapane K. Depression and frailty in later life: a synthetic review. Int J Geriatr Psychiatry. 2012; 27(9): 879-892. doi: 10. 1002/gps. 2807.
7. Buigues C, Padilla-Sánchez C, Garrido JF, Navarro-Martínez R, Ruiz-Ros V, Cauli O. The relationship between depression and frailty syndrome: a systematic review. Aging Ment Health. 2015; 19(9): 762-772. doi: 10. 1080/13607863. 2014. 967174.
8. Bandeen-Roche K, Xue Q-L, Ferrucci L, et al. Phenotype of frailty: characterization in the women's health and aging studies. J Gerontol A Biol Sci Med Sci. 2006; 61(3): 262-266.
9. Xue Q-L, Bandeen-Roche K, Varadhan R, Zhou J, Fried LP. Initial manifestations of frailty criteria and the development of frailty phenotype in the Women's Health and Aging Study II. J Gerontol A Biol Sci Med Sci. 2008; 63(9): 984-990.
10. Newman AB, Gottdiener JS, McBurnie MA, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci. 2001; 56(3): M158-M166. doi: 10. 1093/gerona/56. 3. M158.
11. Paulson D, Lichtenberg PA. Vascular depression: an early warning sign of frailty. Aging Ment Health. 2013; 17(1): 85-93. doi: 10. 1080/13607863. 2012. 692767.
12. Walston J, McBurnie M, Newman A, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the cardiovascular health study. Arch Intern Med. 2002; 162(20): 2333-2341. doi: 10. 1001/archinte. 162. 20. 2333.
13. Leng SX, Xue Q-L, Tian J, Walston JD, Fried LP. Inflammation and frailty in older women. J Am Geriatr Soc. 2007; 55(6): 864-871. doi: 10. 1111/j. 1532-5415. 2007. 01186. x.
14. Mezuk B, Lohman M, Dumenci L, Lapane KL. Are depression and frailty overlapping syndromes in mid-and late-life? A latent variable analysis. Am J Geriatr Psychiatry. 2013; 21(6): 560-569. doi: 10. 1016/j. jagp. 2012. 12. 019.
15. Rodríguez-Mañas L, Féart C, Mann G, et al. Searching for an operational definition of frailty: a Delphi method based consensus statement. The Frailty Operative Definition-Consensus Conference Project. J Gerontol A Biol Sci Med Sci. 2013; 68(1): 62-67. doi: 10. 1093/gerona/gls119.
16. Radloff LS. The CES-D Scale. A self-report depression scale for research in the general population. Appl Psychol Meas. 1977; 1(3): 385-401. doi: 10. 1177/014662167700100306.
17. Yesavage JA. Geriatric Depression Scale. Psychopharm Bull. 1988; 24: 709-711.
18. Sánchez-García S, Sánchez-Arenas R, García-Peña C, et al. Frailty among community-dwelling elderly Mexican people: prevalence and association with sociodemographic characteristics, health state and the use of health services. Geriatr Gerontol Int. 2014; 14(2): 395-402. doi: 10. 1111/ggi. 12114.
19. Jürschik P, Nunin C, Botigué T, Escobar MA, Lavedán A, Viladrosa M. Prevalence of frailty and factors associated with frailty in the elderly population of Lleida, Spain: the FRALLE survey. Arch Gerontol Geriatr. 2012; 55(3): 625-631. doi: 10. 1016/j. archger. 2012. 07. 002.
20. Pegorari MS, Tavares DMDS. Factors associated with the frailty syndrome in elderly individuals living in the urban area. Rev Lat Am Enfermagem. 2014; 22(5): 874-882.
21. Lohman M, Dumenci L, Mezuk B. Sex differences in the construct overlap of frailty and depression: evidence from the Health and Retirement Study. J Am Geriatr Soc. 2014; 62(3): 500-505. doi: 10. 1111/jgs. 12689.
22. Lohman M, Dumenci L, Mezuk B. Depression and frailty in late life: evidence for a common vulnerability. J Gerontol B Psychol Sci Soc Sci. In press 2014.
23. Chang SS, Weiss CO, Xue Q-L, Fried LP. Patterns of comorbid inflammatory diseases in frail older women: the Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci. 2010; 65: 407-413. doi: 10. 1093/gerona/glp181.
24. Feng L, Nyunt MSZ, Feng L, Yap KB, Ng TP. Frailty predicts new and persistent depressive symptoms among community-dwelling older adults: findings from Singapore longitudinal aging study. J Am Med Dir Assoc. 2014; 15(1): 76. e7-e76. e12. doi: 10. 1016/j. jamda. 2013. 10. 001.
25. Collard RM, Comijs HC, Naarding P, et al. Frailty as a predictor of the incidence and course of depressed mood. J Am Med Dir Assoc. 2015; 16(5): 570-578. doi: 10. 1080/13607863. 2013. 827628.
26. Woods NF, LaCroix AZ, Gray SL, et al; Women's Health Initiative. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc. 2005; 53(8): 1321-1330. doi: 10. 1111/j. 1532-5415. 2005. 53405. x.
27. Lakey SL, LaCroix AZ, Gray SL, et al. Antidepressant use, depressive symptoms, and incident frailty in women aged 65 and older from the Women's Health Initiative Observational Study. J Am Geriatr Soc. 2012; 60(5): 854-861. doi: 10. 1111/j. 1532-5415. 2012. 03940. x.
28. LaCroix AZ, Gray SL, Aragaki A, et al. Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women's Health Initiative Observational Study. J Gerontol A Biol Sci Med Sci. 2008; 63(4): 369-375.
29. Makizako H, Shimada H, Doi T, et al. Physical frailty predicts incident depressive symptoms in elderly people: prospective findings from the Obu Study of Health Promotion for the Elderly. J Am Med Dir Assoc. 2015; 16(3): 194-199. doi: 10. 1016/j. jamda. 2014. 08. 017.
30. Rantanen T, Penninx BW, Masaki K, Lintunen T, Foley D, Guralnik JM. Depressed mood and body mass index as predictors of muscle strength decline in old men. J Am Geriatr Soc. 2000; 48: 613-617.
31. Rolland Y, Abellan van Kan G, Bénétos A, et al. Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging. 2008; 12: 335-346.
32. Phillips AC, Upton J, Duggal NA, Carroll D, Lord JM. Depression following hip fracture is associated with increased physical frailty in older adults: the role of the cortisol: dehydroepiandrosterone sulphate ratio. BMC Geriatr. 2013; 13: 60. doi: 10. 1186/1471-2318-13-60.
33. Kim Y-K, Na K-S, Shin K-H, Jung H-Y, Choi S-H, Kim J-B. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(5): 1044-1053. doi: 10. 1016/j. pnpbp. 2007. 03. 004.
34. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009; 65(9): 732-741. doi: 10. 1016/j. biopsych. 2008. 11. 029.
35. Janssen DGA, Caniato RN, Verster JC, Baune BT. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol Clin Exp. 2010; 25(3): 201-215. doi: 10. 1002/hup. 1103.
36. Hannestad J, DellaGioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 2011; 36(12): 2452-2459. doi: 10. 1038/npp. 2011. 132.
37. Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013; 18(9): 963-974. doi: 10. 1038/mp. 2013. 20.
38. Herrmann LL, Masurier ML, Ebmeier KP. White matter hyperintensities in late life depression: a systematic review. J Neurol Neurosurg Psychiatry. 2008; 79(6): 619-624. doi: 10. 1136/jnnp. 2007. 124651.
39. Katz IR. Depression and frailty: the need for multidisciplinary research. Am J Geriatr Psychiatry. 2004; 12(1): 1-5. doi: 10. 1097/00019442-200401000-00001.
40. Leng S, Chaves P, Koenig K, Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc. 2002; 50(7): 1268-1271. doi: 10. 1046/j. 1532-5415. 2002. 50315. x.
41. Hubbard RE, O'Mahony MS, Savva GM, Calver BL, Woodhouse KW. Inflammation and frailty measures in older people. J Cell Mol Med. 2009; 13(9b): 3103-3109. doi: 10. 1111/j. 1582-4934. 2009. 00733. x.
42. Fernández-Garrido J, Ruiz-Ros V, Buigues C, Navarro-Martinez R, Cauli O. Clinical features of prefrail older individuals and emerging peripheral biomarkers: a systematic review. Arch Gerontol Geriatr. 2014; 59(1): 7-17. doi: 10. 1016/j. archger. 2014. 02. 008.
43. Alexopoulos GS, Morimoto SS. The inflammation hypothesis in geriatric depression. Int J Geriatr Psychiatry. 2011; 26(11): 1109-1118. doi: 10. 1002/gps. 2672.
44. Bremmer MA, Beekman ATF, Deeg DJH, et al. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord. 2008; 106(3): 249-255. doi: 10. 1016/j. jad. 2007. 07. 002.
45. Penninx BWJH, Kritchevsky SB, Yaffe K, et al. Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry. 2003; 54(5): 566-572. doi: 10. 1016/S0006-3223(02)01811-5.
46. Tiemeier H, Hofman A, van Tuiji HR, Kiliaan AJ, Meijer J, Breteler MM. Inflammatory proteins and depression in the elderly. Epidemiology. 2003; 14(1): 103-107.
47. Leng SX, Cappola AR, Andersen RE, et al. Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty. Aging Clin Exp Res. 2004; 16(2): 153-157. doi: 10. 1007/BF03324545.
48. van Varsseveld NC, van Bunderen CC, Sohl E, et al. Serum insulin-like growth factor 1 and late-life depression: a population-based study. Psychoneuroendocrinology. 2015; 54: 31-40. doi: 10. 1016/j. psyneuen. 2015. 01. 014.
49. Muller M, Grobbee DE, Thijssen JHH, van den Beld AW, van der Schouw YT. Sex hormones and male health: effects on components of the frailty syndrome. Trends Endocrinol Metab. 2003; 14(6): 289-296. doi: 10. 1016/S1043-2760(03)00083-3.
50. Seidman SN, Araujo AB, Roose SP, et al. Low testosterone levels in elderly men with dysthymic disorder. Am J Psychiatry. 2002; 159(3): 456-459. doi: 10. 1176/appi. ajp. 159. 3. 456.
51. Varadhan R, Walston J, Cappola AR, Carlson MC, Wand GS, Fried LP. Higher levels and blunted diurnal variation of cortisol in frail older women. J Gerontol A Biol Sci Med Sci. 2008; 63(2): 190-195.
52. Johar H, Emeny RT, Bidlingmaier M, et al. Blunted diurnal cortisol pattern is associated with frailty: a cross-sectional study of 745 participants aged 65 to 90 Years. J Clin Endocrinol Metab. 2014; 99(3): E464-E468. doi: 10. 1210/jc. 2013-3079.
53. Bremmer MA, Deeg DJH, Beekman ATF, Penninx BWJH, Lips P, Hoogendijk WJG. Major depression in late life is associated with both hypo-and hypercortisolemia. Biol Psychiatry. 2007; 62(5): 479-486. doi: 10. 1016/j. biopsych. 2006. 11. 033.
54. Penninx BWJH, Beekman ATF, Corsi AM, et al. Late-life depressive symptoms are associated with both hyperactivity and hypoactivity of the hypothalamo-pituitary-adrenal axis. Am J Geriatr Psychiatry. 2007; 15(6): 522-529. doi: 10. 1097/JGP. 0b013e318033ed80.
55. Holland JM, Thompson KL, Rozalski V, Lichtenthal WG. Bereavement-related regret trajectories among widowed older adults. J Gerontol B Psychol Sci Soc Sci. 2014; 69B(1): 40-47. doi: 10. 1093/geronb/gbt050.
56. Brault ME, Ohayon SM, Kwan R, et al. Telomere length and the clinical phenotype of frailty in older adults undergoing cardiac surgery. J Am Geriatr Soc. 2014; 62(11): 2205-2207. doi: 10. 1111/jgs. 13076.
57. Saum K-U, Dieffenbach AK, Müezzinler A, et al. Frailty and telomere length: cross-sectional analysis in 3537 older adults from the ESTHER cohort. Exp Gerontol. 2014; 58: 250-255. doi: 10. 1016/j. exger. 2014. 08. 009.
58. Marzetti E, Lorenzi M, Antocicco M, et al. Shorter telomeres in peripheral blood mononuclear cells from older persons with sarcopenia: results from an exploratory study. Front Aging Neurosci. 2014; 6: 233. doi: 10. 3389/fnagi. 2014. 00233.
59. Wolkowitz OM, Mellon SH, Epel ES, et al. Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress-preliminary findings. PLoS One. 2011; 6(3): e17837. doi: 10. 1371/journal. pone. 0017837.
60. Verhoeven JE, Révész D, Epel ES, Lin J, Wolkowitz OM, Penninx BWJH. Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study. Mol Psychiatry. 2014; 19(8): 895-901. doi: 10. 1038/mp. 2013. 151.
61. Schaakxs R, Verhoeven JE, Oude Voshaar RC, Comijs HC, Penninx BWJH. Leukocyte telomere length and late-life depression. Am J Geriatr Psychiatry. 2015; 23(4): 423-432. doi: 10. 1016/j. jagp. 2014. 06. 003.
62. Wolf SL, Barnhart HX, Kutner NG, McNeely E, Coogler C, Xu T; Atlanta FICSIT Group. Selected as the best paper in the 1990s: Reducing frailty and falls in older persons: an investigation of tai chi and computerized balance training. J Am Geriatr Soc. 2003; 51: 1794-1803.
63. Clegg A, Barber S, Young J, Iliffe S, Forster A. The Home-based Older People's Exercise (HOPE) trial: a pilot randomised controlled trial of a home-based exercise intervention for older people with frailty. Age Ageing. 2014; 43: 687-695. doi: 10. 1093/ageing/afu033.
64. Fusco D, Bochicchio GB, Onder G, Barillaro C, Bernabei R, Landi F; SILVERNET-HC Study Group of Basilicata Region. Predictors of rehabilitation outcome among frail elderly patients living in the community. J Am Med Dir Assoc. 2009; 10: 335-341. doi: 10. 1016/j. jamda. 2009. 02. 004.
65. Kono A, Fujita T, Tsumura C, Kondo T, Kushiyama K, Rubenstein LZ. Preventive home visit model targeted to specific care needs of ambulatory frail elders: preliminary report of a randomized trial design. Aging Clin Exp Res. 2009; 21: 167-173.
66. Landi F, Abbatecola AM, Provinciali M, et al. Moving against frailty: does physical activity matter? Biogerontology. 2010; 11: 537-545. doi: 10. 1007/s10522-010-9296-1.
67. Page ST, Amory JK, Bowman FD, et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab. 2005; 90(3): 1502-1510. doi: 10. 1210/jc. 2004-1933.
68. Perry PJ, Yates WR, Williams RD, Andersen AE, MacIndoe JH, Holman TL. Testosterone therapy in late-life major depression in males. J Clin Psychiatry. 2002; 63(12): 1096-1101.
69. Müller N, Schwarz MJ, Dehning S, et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry. 2006; 11(7): 680-684. doi: 10. 1038/sj. mp. 4001805.
70. Tyring S, Gottlieb A, Papp K, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 2006; 367(9504): 29-35. doi: 10. 1016/S0140-6736(05)67763-X.
71. Raison CL, Rutherford RE, Woolwine BJ, et al. A randomized controlled trial of the tumor necrosis factor-alpha antagonist infliximab in treatment resistant depression: role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013; 70(1): 31-41. doi: 10. 1001/2013. jamapsychiatry. 4.